Années précédentes
Tous les projets CIRI
2021
Ex vivo organ cultures for testing innovative antivirals against SARS-CoV-2 and Nipah virus
- Collaboration between the groups IbIV and VIRIM
Bacteria-eating amoebae to help treat skin infections
- Collaboration between the groups Horigene and EIA
Impact of HPV38 E6/E7 oncoproteins on the immune response to allergens
- Collaboration between the groups ICL and EIA
2020
Development of Cecal ligation and puncture (CLP) mouse sepsis model
- Collaboration between the groups NLRP3 and NOPAB
Deciphering interactions between metabolic pathways and the innate antiviral response: a first proof of concept with the Hepatitis B virus
- Collaboration between the groups HepVir and VIRIM
2019
Autophagy and maturation statuses in human primary dendritic cells upon HTLV-1 infection
- Collaboration between the groups APY and OR
Virus-Natural Killer cell repertoire interaction
- Collaboration between the groups LYACTS and Lp2L
2018
The lung-on-a-chip as a new platform for studying respiratory diseases
- Collaboration between the groups LegioPath, VirPath Stapath
Single-cell response in space
- Collaboration between the groups NOPAB and EIA
Generation of a new congenic mouse to improve HSC engraftment and adoptive cell transfer experiments: the B6.1/CIRI mouse
- Collaboration between the groups ICL and LYACTS
Analyzing centrosomal alterations by oncogenic viruses using proximity-dependent Biotin Identification
- Collaboration between the groups EBV-OR
2017
Study of the effect of fusion inhibitory peptides in the prevention and treatment of Influenza virus infection
- Collaboration between the groups IbIV and VirPath
2016
Development of Crispr/cas9 genome‐wide screens in primary cells: Understanding the macrophage‐NK cells cross‐talk during intracellular bacterial infections
- Collaboration between the groups LYACTS, I2BA and EVIR
Implementing Single cell RNA-seq at the CIRI
- Collaboration between the groups REVE and ICL
Tn-seq: Comprehensive genetics of host-pathogen interaction and acquired resistance
- Collaboration between the groups Horigene, LegioPath and Stapath
2015
Implementing research on Ebola virus at the CIRI
- Collaboration between the groups BMPV, REVE and VIV
Implementing research on Crimean Congo Hemorrhagic Fever virus (CCHF) at the CIRI
- Collaboration between the groups IbIV, APY, EVIR, REVE and Fondation Mérieux